Holen Sie sich die Stockscreener-App
0.1406
4.23%
0.0057
Handel nachbörslich:
.14
-0.0006
-0.43%
Schlusskurs vom Vortag:
$0.1349
Offen:
$0.1307
24-Stunden-Volumen:
75.76M
Relative Volume:
5.07
Marktkapitalisierung:
$2.83M
Einnahmen:
$19.57M
Nettoeinkommen (Verlust:
$-25.12M
KGV:
-0.0608
EPS:
-2.3114
Netto-Cashflow:
$-19.71M
1W Leistung:
-0.71%
1M Leistung:
-13.85%
6M Leistung:
-86.08%
1J Leistung:
-95.07%
1-Tages-Spanne:
$0.124
$0.1446
1-Wochen-Bereich:
$0.124
$0.15
52-Wochen-Spanne:
$0.124
$3.105
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Firmenname
Vivos Therapeutics Inc
Sektor
Branche
Telefon
(866)908-4867
Adresse
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
0.1406 | 2.83M | 19.57M | -25.12M | -19.71M | -2.3114 |
ABT
Abbott Laboratories
|
102.45 | 177.28B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.63 | 121.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
304.40 | 116.76B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.58 | 66.06B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.29 | 50.89B | 6.30B | 1.07B | 1.09B | 1.8406 |
Vivos Therapeutics Inc Aktie (VVOS) Neueste Nachrichten
Form 4 Vivos Therapeutics Inc For: 28 September By Investing.com - Investing.com Canada
Form 4 Vivos Therapeutics Inc For: 28 September By Investing.com - Investing.com South Africa
Form 4 Vivos Therapeutics Inc For: 28 September By Investing.com - Investing.com India
Form 4 Vivos Therapeutics Inc For: 28 September By Investing.com - Investing.com UK
ME Therapeutics Holdings (CN:METX:CNX) Stock Rebounds 14.29%: In Vivo CAR-T and mRNA STING Program Pacing, Micro-Cap Liquidity Dynamics, and Preclinical Biotech Re-Rating Examined - kalkine.ca
TScan Therapeutics (Nasdaq:TCRX)Stock Analysis - simplywall.st
Director at Vivos Therapeutics (VVOS) receives 12,000 stock options - Stock Titan
[Form 4] Vivos Therapeutics, Inc. Insider Trading Activity - Stock Titan
VVOS Form 4 FilingsVivos Therapeutics, Inc. SEC Form 4 - Stock Titan
Vivos Therapeutics (VVOS) grants director 12,000 options - Stock Titan
TPST Stock Spikes As Tempest Therapeutics Expands In Vivo CAR-T Pipeline - timothysykes.com
Vivos Issues 11.45M Shares to Retire $2.86M of Debt in Dilutive Exchange - Minichart
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com Nigeria
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com South Africa
Vivos to Issue 11.4M Shares to Settle $2.86M in Debt - minichart.com.sg
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com Canada
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com India
Vivos exchanges $2.9m debt for common stock with Streeterville - Investing.com
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com UK
Vivos Therapeutics Announces Material Debt Reduction - The Manila Times
Vivos Therapeutics Announces Material Debt Reduction - Yahoo Finance
Vivos Therapeutics Swaps $2.86M of Streeterville Debt for Up to 11.45M Shares - TradingView
Vivos Therapeutics (VVOS) investor lists 122,963 shares, under 5% - Stock Titan
Regional Sleep & Airway Medicine Center to Be Established in Palm Beach County, Fla - Sleep Review
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference - marketscreener.com
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference - TradingView
Vivos CEO to present at 2026 Moody Capital Solu... - Pluang
Vivos Therapeutics Surges as Investors Weigh Nevada Growth Updates and Florida Expansion Plan - Moomoo
Vivos Therapeutics Surges as Investors Weigh Nevada Growth Updates and Florida Expansion Plan - Quiver Quantitative
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center - The Manila Times
Vivos Therapeutics partners with Florida cardiology group for sleep center - Investing.com
Vivos Therapeutics partners with Florida cardiology group for sleep center - Investing.com India
Vivos Therapeutics partners with Florida cardiology group for sleep center By Investing.com - Investing.com UK
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center - marketscreener.com
Vivos plans a Florida sleep center built to treat 250 patients a month - Stock Titan
Vivos Therapeutics Inc. (VVOS) Peer Comparison – Compare with Others - Value Research
Vivos Therapeutics (VVOS) grants 250K shares, 150K options - Stock Titan
Vivos Therapeutics reports 212% rise in Nevada patient referrals By Investing.com - Investing.com Canada
Vivos Therapeutics reports 212% rise in Nevada patient referrals By Investing.com - Investing.com India
Vivos Therapeutics reports 212% rise in Nevada patient referrals By Investing.com - Investing.com UK
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers - Barchart.com
Vivos' Nevada sleep referrals rose 212% before a new center opens - Stock Titan
Vivos Therapeutics Reports 212% Increase in Nevada Sleep & Airway Medicine Center Referrals Ahead of Henderson Facility Opening - Quiver Quantitative
Vivos Therapeutics Inc (VVOS) Stock News Today - TradingKey
Vivos Therapeutics opens Henderson facility with $10M capacity - Investing.com
Vivos Therapeutics Opens Nevada Sleep Treatment Center - marketscreener.com
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment - The Manila Times
Vivos Therapeutics opens Henderson facility with $10M capacity By Investing.com - Investing.com Canada
Vivos Therapeutics Opens New Henderson Sleep Center, Expects Capacity to More Than Double to Over $10 Million Annually - Moomoo
Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
7.98%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):